General Information of Drug Inactive Ingredient (DIG) (ID: E00517)

DIG Name
Tannic acid
Synonyms
TANNIC ACID; 1401-55-4; Gallotannin; Glycerite; Chinese gallotannin; Gallotannic acid; 5424-20-4; MFCD00066397; MLS001335996; CHEBI:81066; SMR000857330; DSSTox_CID_6076; DSSTox_RID_78006; DSSTox_GSID_26076; FEMA No. 3042; Quebracho extract; tannic-acid; CAS-1401-55-4; Tannic acid, ACS reagent; C76H52O46; NSC656273; NSC-656273; NCGC00095101-01; EINECS 226-562-9; Tannin (Tannic acid); Tannic acid, technical; Tannic acid, technical grade; MLS001335995; SCHEMBL409692; Tannic acid, SAJ first grade; CHEMBL506247; GTPL4319; BDBM60986; DTXSID00892987; Tannic acid, puriss., 95.0%; cid_16129778; Tox21_111422; Tox21_300079; BDBM50442879; s3951; AKOS015951319; Tannic acid, Vetec(TM) reagent grade; CCG-270692; beta-D-Glucose pentakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate); NCGC00186054-01; NCGC00186054-02; NCGC00253925-01; Tannic acid, tested according to Ph.Eur.; C17409; Tannic acid, Source: Chinese natural gall nuts; Q427956; Q-201780; Tannic acid, puriss., meets analytical specification of USP, powder; Tannic acid, United States Pharmacopeia (USP) Reference Standard; .Beta.-D-glucopyranose, pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate]; beta-D-Glucopyranose pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate]; (2R,3R,4S,5R,6S)-4,5,6-tris({3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]phenyl}carbonyloxy)-2-[({3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]phenyl}carbonyloxy)methyl]oxan-3-yl 3,4-dihydroxy-5-[(3,4,5-trihydroxyphenyl)carbonyloxy]benzoate; [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxy-benzoyl]oxy]tetrahydropyran-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate
DIG Function
Antioxidant
Formula
C76H52O46
Canonical SMILES
C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O
InChI
1S/C76H52O46/c77-32-1-22(2-33(78)53(32)92)67(103)113-47-16-27(11-42(87)58(47)97)66(102)112-21-52-63(119-72(108)28-12-43(88)59(98)48(17-28)114-68(104)23-3-34(79)54(93)35(80)4-23)64(120-73(109)29-13-44(89)60(99)49(18-29)115-69(105)24-5-36(81)55(94)37(82)6-24)65(121-74(110)30-14-45(90)61(100)50(19-30)116-70(106)25-7-38(83)56(95)39(84)8-25)76(118-52)122-75(111)31-15-46(91)62(101)51(20-31)117-71(107)26-9-40(85)57(96)41(86)10-26/h1-20,52,63-65,76-101H,21H2/t52-,63-,64+,65-,76+/m1/s1
InChIKey
LRBQNJMCXXYXIU-PPKXGCFTSA-N
Physicochemical Properties Molecular Weight 1701.2 Topological Polar Surface Area 778
XlogP 6.2 Complexity 3570
Heavy Atom Count 122 Rotatable Bond Count 31
Hydrogen Bond Donor Count 25 Hydrogen Bond Acceptor Count 46

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Doxylamine DMKOXFE Allergic rhinitis [CA08.0] Doxylamine 5 mg tablet F07034
------------------